Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies.

Li J, Florian J, Campbell E, Schrieber SJ, Bai JPF, Weaver JL, Hyland PL, Thway TM, Matta MK, Lankapalli RH, Narayanasamy S, Dancy J, Zusterzeel R, Tyson JY, Prentice KW, Jackson KC, Patel V, Rouse RL, Wang YC, Strauss DG.

Clin Pharmacol Ther. 2019 Oct 31. doi: 10.1002/cpt.1653. [Epub ahead of print] No abstract available.

PMID:
31667825
2.

Type II Secretion Promotes Bacterial Growth within the Legionella-Containing Vacuole in Infected Amoebae.

White RC, Truchan HK, Zheng H, Tyson JY, Cianciotto NP.

Infect Immun. 2019 Oct 18;87(11). pii: e00374-19. doi: 10.1128/IAI.00374-19. Print 2019 Nov.

PMID:
31405960
3.

Type II Secretion-Dependent Aminopeptidase LapA and Acyltransferase PlaC Are Redundant for Nutrient Acquisition during Legionella pneumophila Intracellular Infection of Amoebas.

White RC, Gunderson FF, Tyson JY, Richardson KH, Portlock TJ, Garnett JA, Cianciotto NP.

MBio. 2018 Apr 17;9(2). pii: e00528-18. doi: 10.1128/mBio.00528-18.

4.

The novel Legionella pneumophila type II secretion substrate NttC contributes to infection of amoebae Hartmannella vermiformis and Willaertia magna.

Tyson JY, Vargas P, Cianciotto NP.

Microbiology. 2014 Dec;160(Pt 12):2732-44. doi: 10.1099/mic.0.082750-0. Epub 2014 Sep 24.

5.

Supplemental Content

Loading ...
Support Center